STEM
Cambridge Biomedical Campus to clinic: translating scientific innovation
As part of Cambridge Wide Open Week, the Cambridge Biomedical Campus is opening its doors for a special morning of innovation, collaboration and discovery. ...
Cash is King: Maximising Your Cash Runway Seminar
Securing investment, whether from investors, grants, partnerships or customers is the largest challenges life science companies face. This seminar will present and discuss approaches to robust cash flow forecasting, making the most of non-dilutive capital and structuring deals for impac...
Anthias Consulting's flexible training option for their Complete GC and LC courses
At Anthias Consulting, their Complete GC and GC‑MS and Complete LC and LC‑MS training courses provide you with the flexibility to learn your own way to suit your role, experience, budget and schedule. ...
Gulf Genesis Presented by ElyARC: Emergency Seminar – Business Resilience and Supply Chain Preparedness
Join us in person at the ElyARC Business Seminar to discuss how businesses can become more resilient in risky times. ...
How science companies become the first brand buyers think of
Many science and Life Sciences and Biotech companies market themselves through product features and technical capabilities, but the problem is that buyers rarely remember companies because of their technical specifications alone. Companies that clearly associate themselves with a partic...
Why many B2B content strategies stop delivering results
Most B2B companies produce content consistently, but fewer step back and assess whether that content is actually helping the business grow.Over time, content libraries often become fragmented: outdated articles remain live, messaging changes between channels, and new content is created ...
Why omnichannel lead strategies matter in complex B2B markets
Many B2B companies operate across multiple marketing channels, yet prospects often experience those channels as disconnected.A prospect may discover a company through LinkedIn, attend a webinar weeks later, download a technical guide, and only engage with sales months after that. When t...
Why Life Sciences and Biotech companies lose pipeline momentum at the bottom of the funnel
Many Life Sciences and Biotech companies invest heavily in awareness, content, and lead generation, yet still struggle to convert opportunities consistently at the final stage - the so called 'bottom of the funnel'.In our experience, the issue is often not lead volume but friction at th...
Why the middle of the funnel is where most Life Science and Biotech growth stalls
Many B2B organisations focus heavily on generating leads and closing deals, but the middle of the funnel is often where growth actually stalls.This stage is where prospects move from initial interest into active evaluation. In sectors such as Life Sciences, buying decisions are rarely i...
Yourgene Health launches Insight DPYD Assay
Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients. ...